September 2015

Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management

Author Affiliations
  • 1Currently a medical student at University of Illinois College of Medicine, Chicago
  • 2Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 3Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Dermatol. 2015;151(9):1009-1013. doi:10.1001/jamadermatol.2015.0250

Importance  Atopic dermatitis (AD) is a common skin condition treated by dermatologists, allergists, pediatricians, and primary care physicians. Several treatment guidelines and therapeutic parameters exist for the management of this disease. Health care professionals may be unaware of guidelines created by specialty organizations other than their own.

Objective  To review, compare, and contrast the most recent AD management guidelines.

Evidence Review  The guidelines for AD management published by the American Academy of Dermatology 2014 work group were compared with those created by the 2012 Joint Task Force on Practice Parameters representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. International guidelines created by the 2012 European Task Force on Atopic Dermatitis and the 2013 Asia–Pacific Consensus Group for Atopic Dermatitis were also considered.

Findings  Several differences among the guidelines suggest that there may be disparity in the perceptions of AD between US dermatologists and allergists and health care professionals in other areas of the world. There are notable differences among the guidelines regarding the recommendations for the use of diluted bleach baths, vitamin D, and environmental modifications.

Conclusions and Relevance  Comparison of different guidelines may ultimately augment knowledge of treatment strategies and enhance realization of biases in the understanding and management of AD.